Morgan Stanley raised its position in shares of Clorox Company (The) (NYSE:CLX) by 31.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 996,369 shares of the company’s stock after buying an additional 241,210 shares during the period. Morgan Stanley owned about 0.77% of Clorox Company (The) worth $134,342,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Korea Investment CORP increased its position in shares of Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the last quarter. Crossvault Capital Management LLC increased its stake in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock worth $4,676,000 after buying an additional 1,285 shares in the last quarter. Park National Corp OH increased its stake in Clorox Company (The) by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock worth $733,000 after buying an additional 331 shares in the last quarter. HighPoint Advisor Group LLC increased its stake in Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock worth $5,509,000 after buying an additional 1,245 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Clorox Company (The) by 0.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 411,100 shares of the company’s stock worth $49,344,000 after buying an additional 2,566 shares in the last quarter. Institutional investors and hedge funds own 70.29% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) traded up 0.75% during midday trading on Monday, reaching $135.50. 584,768 shares of the company’s stock were exchanged. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The company has a market cap of $17.45 billion, a price-to-earnings ratio of 26.77 and a beta of 0.40. The stock’s 50 day moving average price is $134.79 and its 200 day moving average price is $133.07.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the previous year, the business posted $1.30 EPS. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. Equities analysts anticipate that Clorox Company will post $5.68 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Morgan Stanley Raises Stake in Clorox Company (The) (NYSE:CLX)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/08/07/morgan-stanley-acquires-241210-shares-of-clorox-company-the-nyseclx-updated-updated-updated.html.

A number of analysts have recently issued reports on the stock. UBS AG reaffirmed a “sell” rating and set a $121.00 price objective (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Royal Bank Of Canada set a $115.00 price target on shares of Clorox Company (The) and gave the stock a “hold” rating in a research note on Monday, April 24th. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target for the company. in a research note on Tuesday, April 18th. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Finally, Barclays PLC lowered their price target on shares of Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating for the company in a research note on Friday. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $129.13.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.